The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?

The early reports on intraocular bevacizumab injections talked about a transient predictable probably volume-related rise in intraocular pressure (IOP). As the usage of the drug increased across the globe, sustained IOP elevation was noted. This article provides an insightly into the causes of IOP s...

Descripción completa

Detalles Bibliográficos
Autores principales: Skalicky, Simon E, Clement, Colin I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2012
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161767/
https://www.ncbi.nlm.nih.gov/pubmed/28028346
http://dx.doi.org/10.5005/jp-journals-10008-1106
Descripción
Sumario:The early reports on intraocular bevacizumab injections talked about a transient predictable probably volume-related rise in intraocular pressure (IOP). As the usage of the drug increased across the globe, sustained IOP elevation was noted. This article provides an insightly into the causes of IOP spikes and its impact on glaucoma practice. HOW TO CITE THIS ARTICLE: Skalicky SE, I Clement C. The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services? J Current Glau Prac 2012;6(2):55-57.

Ejemplares similares